At Kallyope, we focus on big health challenges that matter to patients and families. We aim to discover and develop effective, easy to use, and well-tolerated oral agents addressing metabolic, neurological, and gastrointestinal diseases.
Inside every human body is a complex, unexplored network of metabolic, neurological, and gastrointestinal interconnections. Our scientists are unlocking the mysteries of this network to develop oral therapies for obesity and diabetes; neurological disorders, including migraine; and gastrointestinal disease, including celiac disease.
Based in New York City, we are home to some of the world’s most intrepid scientific minds from the world’s top institutions, working alongside a seasoned team with a proven track record of success in drug discovery and development.
Together, we are leveraging multiple sophisticated technologies and internally-developed capabilities to bring fundamentally new solutions to some of the most pressing unmet needs in human health.
Company Details
- Employees
- 70
- Address
- 430 E. 29th Street, New York,new York 10016,united States
- in****@****ope.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- kallyope.com
- HQ
- New York, New York
Kallyope Questions
Kallyope's website is kallyope.com
Kallyope's LinkedIn profile is https://www.linkedin.com/company/kallyope
Kallyope has
70 employees.
View email and phone details for 70
employees at Kallyope.
Kallyope's industry is
Biotechnology Research
Kallyope's top competitors are
Bluerock Therapeutics,
Gameto,
Eikon Therapeutics,
Meiragtx,
Neptune Bio,
Nilo Therapeutics,
Axsome Therapeutics, Inc.,
Xaira Therapeutics,
Intra-Cellular Therapies,
Celmatix Therapeutics.
Kallyope's support email address is info@kallyope.com
Kallyope's categories are Biotechnology Research
